NCT00706134 - Efficacy and Safety of Aliskiren 75 mg, 150 mg, and 300 mg in Elderly Patients With Essential Hypertension When Given With a Light Meal in a 8 Week Placebo-controlled Study | Biotech Hunter

Enrollment

756

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions

Hypertension

Interventions

DRUG

Placebo

Placebo tablet taken once daily in the morning with a light meal.

DRUG

Aliskiren 75 mg

Aliskiren 75 mg tablet taken once daily in the morning with a light meal.

DRUG

Aliskiren 150 mg

Aliskiren 150 mg tablet taken once daily in the morning with a light meal.

DRUG

Aliskiren 300 mg

Aliskiren 300 mg tablet taken once daily in the morning with a light meal.

Trial Locations (8)

Investigative Site, Buenos Aires

Investigative Site, Prague

Investigative Site, Berlin

Investigative Site, Reykjavik

Investigative Site, Rome

Investigative Site, Amsterdam

Investigative Site, Warsaw

Investigative Site, Bratislava